Skip to Content
Advanced practice nurse cardiovascular clinician

Advanced practice nurse cardiovascular clinician

Anderson, Kelley M., editor

"Focusing on the interprofessional team, this cardiovascular resource provides evidence-based knowledge and guidance for advanced practice nurses in a variety of care settings. Its clinically relevant and directly applicable information is presented in an accessible and well-organized format. The book encompasses clinical findings, diagnostic testing, state-of-the-art procedures, and therapeutic interventions commonly used in inpatient and outpatient clinical cardiology."--Publisher

eBook, Electronic resource, Book. English. Electronic books.
Published New York, NY : Springer Publishing Company, LLC 2016
Rate this

This resource is available electronically from the following locations

Details

Statement of responsibility: Kelley M. Anderson, editor
ISBN: 0826138578, 0826138586, 9780826138576, 9780826138583
Note: Online resource; title from PDF title page (EBSCO, viewed November 25, 2015).
Note: Includes bibliographical references.
Physical Description: 1 online resource
Subject: Advanced Practice Nursing.; Cardiovascular Diseases nursing.; Cardiovascular Nursing methods.; MEDICAL Diseases.; MEDICAL Evidence-Based Medicine.; HEALTH & FITNESS Diseases General.; Cardiovascular system Diseases Nursing.; MEDICAL Clinical Medicine.; Nurse practitioners.; MEDICAL Internal Medicine.; Cardiovascular system Diseases Treatment.
Local note: eBooks on EBSCOhost EBSCO eBook Nursing Collection

Contents

  1. Overview of cardiovascular care
  2. Chronic cardiovascular conditions
  3. Cardiac electrophysiology
  4. Vascular disorders
  5. Acute cardiovascular conditions
  6. Cardiovascular diagnostics
  7. Cardiovascular therapeutics and interventions.
  8. Share The Advanced Practice Nurse Cardiovascular Clinician
  9. Section I: Overview of Cardiovascular Care
  10. The Interprofessional Team: Focus on Quality
  11. Health Care Delivery System Redesign
  12. Interprofessional Collaboration
  13. Cardiovascular Team Members
  14. Techniques for Implementation of Interdisciplinary Collaboration with the Health Care Team
  15. Focus on Quality
  16. The Cardiovascular History
  17. Identifying Information
  18. Chief Concern
  19. History of Present Illness
  20. Past Medical History
  21. Past Procedural and Surgical History
  22. Review of Systems
  23. Allergies and Reactions
  24. Medication History
  25. Health Promotion and Disease Prevention
  26. Collaborators
  27. Family History
  28. Social History
  29. Cognitive and Functional Abilities
  30. Patient Expectations, Goals, and Values
  31. Cardiovascular Risk Stratification and Diagnostic Reasoning
  32. Coding the Visit
  33. Privilege and Challenges
  34. The Comprehensive Cardiovascular Physical Examination
  35. The General Survey
  36. Cardiovascular Assessment
  37. Cardiovascular-Related Findings in Other Body Areas and Systems
  38. Functional Capacity
  39. Population Considerations
  40. Billling and Coding
  41. Preoperative Cardiovascular Risk Assessment and Evaluation for Noncardiac Surgery
  42. Preoperative Interview
  43. Preoperative Physical Examination
  44. Preoperative Risk Evaluation
  45. Cardiopulmonary Diagnostic Testing
  46. Perioperative Management
  47. Section II: Chronic Cardiovascular Conditions
  48. Hypertension
  49. Classifications
  50. Stages of Hypertension
  51. Pathophysiology
  52. Complications of Hypertension
  53. Clinical Presentation
  54. Physical Examination
  55. Diagnostic Testing
  56. Secondary Hypertension
  57. Diagnosis of Hypertension
  58. Therapeutic Management of Hypertension.
  59. Pharmacologic Therapy
  60. Follow-Up
  61. Referral
  62. Lipid Metabolism Disorders
  63. Pathophysiology
  64. Classification Systems
  65. Secondary Causes of Lipoprotein Abnormalities
  66. Clinical Presentation
  67. Physical Examination
  68. Screening
  69. Diagnostic Laboratory Evaluation
  70. Risk Stratification
  71. Therapeutic Lifestyle Modifications
  72. Pharmacologic Therapy
  73. Special Considerations
  74. Follow-Up and Referrals
  75. Diabetes and the Metabolic Syndrome
  76. Pathophysiology
  77. The Metabolic Syndrome
  78. Clinical Presentation
  79. Physical Examination
  80. Diagnostic Testing
  81. Nonpharmacological Management
  82. Pharmacological Therapy
  83. Follow-Up and Referrals
  84. Chest Pain
  85. Etiologies of Cardiac Chest Pain
  86. Etiologies of Non-Cardiac Chest Pain
  87. Stable Ischemic Heart Disease
  88. Pathophysiology
  89. Clinical Presentation
  90. Health History
  91. Physical Examination
  92. Cardiac Risk Assessment in the Asymptomatic Adult
  93. Noninvasive Diagnostic Testing
  94. Cardiac Risk Assessment in the Symptomatic Adult
  95. Diagnostic Evaluation
  96. Therapeutic Management of SIHD
  97. Nonpharmacologic Management
  98. Pharmacologic Therapy
  99. Advanced Therapeutic Management of SIHD
  100. Special Considerations for SIHD
  101. Valvular Heart Disease
  102. The Mitral Valve
  103. Mitral Valve Prolapse
  104. Chronic MR
  105. Mitral Stenosis
  106. The Aortic Valve
  107. Aortic Valve Regurgitation
  108. Aortic Valve Stenosis
  109. The Tricuspid Valve
  110. Tricuspid Valve Regurgitation
  111. The Pulmonary Valve
  112. Pulmonary Valve Regurgitation
  113. Pulmonary Valve Stenosis
  114. The Prosthetic Valve
  115. Chronic Heart Failure
  116. Pathophysiology
  117. Cardiomyopathy
  118. HF Classification
  119. Diagnosis
  120. Diagnostic Evaluation
  121. HF Risk Stratification
  122. Nonpharmacologic Management
  123. Pharmacologic Therapy
  124. Cardiovascular Implantable Electronic Device Therapy.
  125. Medication Adjustments in Women and the Older Adult
  126. Pre-Discharge Risk Assessment
  127. Post-Discharge Management of ACS Patients
  128. Complications of ACS
  129. Acute Decompensated Heart Failure
  130. Pathophysiology
  131. Clinical Presentation
  132. Physical Examination
  133. Diagnostic Testing
  134. Risk Stratification
  135. Management
  136. Ultrafiltration
  137. Fluid and Sodium Restriction
  138. Mechanical Circulatory Support
  139. Transitions in Care
  140. Shock States: Cardiogenic and Obstructive
  141. Cardiogenic Shock
  142. Obstructive Shock
  143. Aortic Dissection
  144. Pathophysiology
  145. Diagnosis
  146. Clinical Presentation
  147. Physical Examination
  148. Diagnostic Testing
  149. Management
  150. Complications of Aortic Dissection
  151. Follow-Up
  152. Pericarditis and Infective Endocarditis
  153. Pericarditis
  154. Infective Endocarditis
  155. Syncope
  156. Pathophysiology
  157. Etiology
  158. Diagnosis
  159. Clinical Presentation
  160. Physical Examination
  161. Diagnostic Testing
  162. Risk Stratification
  163. Management
  164. Sudden Cardiac Death and Cardiac Arrest
  165. Etiology
  166. Diagnosis
  167. Clinical Presentation
  168. Physical Examination
  169. Diagnostic Testing
  170. Management
  171. Predicting Neurologic Outcomes
  172. Long-Term Management of CA Survivors
  173. ICDs as Primary Prevention for SCD
  174. Section VI: Cardiovascular Diagnostics
  175. Diagnostic Laboratory Evaluations
  176. Serum Chemistries
  177. Measures of Kidney Function
  178. Glucose Metabolism
  179. Measures of Hepatic Function
  180. Hematologic Studies
  181. Coagulation Studies
  182. Lipid Metabolism
  183. Inflammatory Markers
  184. Other Related Studies
  185. Cardiac Biomarkers
  186. Therapeutic Drug Monitoring
  187. Cardiac Genetic Testing
  188. Urine Studies
  189. General Recommendations
  190. Noninvasive Diagnostic Testing: Electrocardiograph and Ultrasound
  191. Electrocardiograph Tests
  192. Ultrasound Tests.
  193. Noninvasive Diagnostic Testing: Radiographic and Nuclear Imaging
  194. Radiographic Tests
  195. Nuclear Imaging
  196. Clinical Decision Making
  197. Section VII: Cardiovascular Therapeutics and Interventions
  198. Integration of Therapeutic Lifestyle Interventions
  199. Nutritional Interventions
  200. Weight Management and Weight Loss
  201. Smoking Cessation and Substance Abuse
  202. Physical Activity
  203. Complementary Therapies
  204. Cardiac Rehabilitation
  205. Sexual Function
  206. Pharmacotherapeutics of Hypertension and Hypertensive Emergencies
  207. Pharmacotherapeutics of Chronic Hypertension
  208. Pharmacotherapeutics of Hypertensive Emergencies
  209. Pharmacotherapeutics of Hyperlipidemia
  210. Pathophysiology
  211. HMG-CoA Reductase Inhibitors (Statins)
  212. Nicotinic Acid
  213. Bile Acid Sequestrants
  214. Fibrates
  215. Cholesterol Absorption Inhibitor
  216. Fish Oil
  217. Antithrombotic Therapy and Pharmacotherapeutics of Thrombotic Disease States
  218. Pharmacotherapeutics of Thromboembolic Disease States
  219. Hemostasis
  220. Pharmacology of the Antithrombotic Agents
  221. Pharmacotherapy of Thromboembolic Disease States
  222. Pharmacotherapeutics of Ischemic Heart Disease
  223. Chronic Stable Angina
  224. Acute Coronary Syndromes: UA, NSTEMI, and STEMI
  225. Dual Antiplatelet Therapy
  226. Anticoagulation
  227. GP IIB/IIIA Inhibitors
  228. High-Dose Statin Therapy
  229. Beta Adrenergic Receptor Blockers
  230. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
  231. Protease-Activated Receptor-1
  232. St-Segment Elevation Myocardial Infarctions
  233. CABG Post-Angiography
  234. Pharmacotherapeutics of Heart Failure and Acute Decompensated Heart Failure
  235. Pharmacologic Therapy: Chronic HF
  236. Pharmacotherapy of HF Management
  237. Acute Decompensated Heart Failure
  238. Pharmacotherapeutics of Cardiac Arrhythmias
  239. Class I
  240. Class II.